Vanderbilt University Institute of Imaging Science Archives
New VUSM master’s program offers broad training in biomedical imaging
Nov. 3, 2022—A new Master of Imaging Science program at Vanderbilt will immerse students in the full spectrum of biomedical imaging and provide hands-on clinical and research experience.
Tracking the aging brain
Jun. 6, 2022—The macrostructure — volume, area and length — of the brain’s white matter is useful for studying aging and could be a sensitive marker for neurodegenerative disorders such as Alzheimer’s disease, Vanderbilt researchers reported.
PET imaging probe for Alzheimer’s disease
Feb. 24, 2022—Vanderbilt researchers report on a new PET imaging probe that will be useful for exploring Alzheimer’s disease pathology.
VUMC’s Smith elected to AIMBE College of Fellows
Feb. 24, 2022—Vanderbilt's Seth Smith, PhD, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering.
The power of white matter
Nov. 11, 2021—Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions.
White matter and schizophrenia
Sep. 2, 2021—Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed.
Imaging guidance for nerve repair
Feb. 9, 2021—A noninvasive, quantitative MRI method could be used after surgical repair of traumatic peripheral nerve injury to help clinicians make decisions about whether additional surgical interventions are needed.
Grant bolsters VUIIS ‘deep tissue’ imaging research
Dec. 2, 2020—Researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) have received a $1 million grant from the Chan Zuckerberg Initiative to develop “deep tissue” imaging methods that can peer into the furthest corners of the body.
Imaging “biomarker” for Alzheimer’s disease progression
Nov. 16, 2020—Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.
Blocking tumor ‘signals’ and ‘fuel’
Aug. 25, 2020—Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.
Imaging breast cancer cell size
Feb. 10, 2020—A noninvasive MRI approach assesses breast tumor cell size and could be a useful way to evaluate early response to neoadjuvant therapy.
Imaging nerve regeneration
Jan. 28, 2020—Diffusion MRI may provide a noninvasive approach to assess nerve regeneration and distinguish successful from unsuccessful repairs earlier.
